Longevity Health Holdings Inc (NASDAQ: XAGE) is -63.45% lower on its value in year-to-date trading and has touched a low of $2.63 and a high of $87.90 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The XAGE stock was last observed hovering at around $3.26 in the last trading session, with the day’s loss setting it -0.2%.
Currently trading at $3.06, the stock is -26.86% and -34.89% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.8 million and changing -6.13% at the moment leaves the stock -71.12% off its SMA200. XAGE registered -95.02% loss for a year compared to 6-month loss of -56.03%. The firm has a 50-day simple moving average (SMA 50) of $4.7005 and a 200-day simple moving average (SMA200) of $10.595575.
The stock witnessed a -42.50% gain in the last 1 month and extending the period to 3 months gives it a -57.30%, and is 9.29% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 18.05% over the week and 13.93% over the month.
Longevity Health Holdings Inc (XAGE) has around 15 employees, a market worth around $3.07M and $0.56M in sales. Profit margin for the company is -1516.61%. Distance from 52-week low is 16.35% and -96.52% from its 52-week high.
25.0 institutions hold shares in Longevity Health Holdings Inc (XAGE), with institutional investors hold 9.12% of the company’s shares. The shares outstanding are 1.00M, and float is at 0.76M with Short Float at 1.92%. Institutions hold 7.29% of the Float.
Longevity Health Holdings Inc (XAGE) Insider Activity
The most recent transaction is an insider purchase by Upton Richard A, the company’s Director. SEC filings show that Upton Richard A bought 5,000 shares of the company’s common stock on Sep 13 ’24 at a price of $0.47 per share for a total of $2336.0. Following the purchase, the insider now owns 15000.0 shares.
Longevity Health Holdings Inc disclosed in a document filed with the SEC on Sep 06 ’24 that Gregory Kathryn (Director) bought a total of 1,260 shares of the company’s common stock. The trade occurred on Sep 06 ’24 and was made at $0.51 per share for $643.0. Following the transaction, the insider now directly holds 22500.0 shares of the XAGE stock.
Still, SEC filings show that on Sep 06 ’24, Sturgeon Patrick A (Director) acquired 1,261 shares at an average price of $0.51 for $643.0. The insider now directly holds 18,051 shares of Longevity Health Holdings Inc (XAGE).
